Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians

Respiratory Medicine

Volumn 99, Issue 1, 2005, Pages 107-110

  Hegab, A E ^a   Sakamoto, T ^a   Uchida, Y ^a   Nomura, A ^a   Ishii, Y ^a   Morishima, Y ^a   Mochizuki, M ^a   Kimura, T ^a   Saitoh, W ^a   Kiwamoto, T ^a   Iizuka, T ^a   Massoud, H H ^b   Massoud, H M ^b   Hassanein, K M ^b   Sekizawa, Kiyo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

COPD; Egyptian; Polymorphism; TIMP2

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EGYPT; ENZYME ACTIVITY; ETHNOLOGY; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPIROMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSLATION INITIATION; VITAL CAPACITY;

CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 19944417988     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.05.017     Document Type: Article

References (14)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76
2. Sandford A.J. Silverman E.K. Chronic obstructive pulmonary disease 1: Susceptibility factors for COPD the genotype-environment interaction Thorax 57 2002 736-741
3. Silverman E.K. Speizer F.E. Risk factors for the development of chronic obstructive pulmonary disease Med Clin North Am 80 1996 501-522
4. Joos L. Pare P.D. Sandford A.J. Genetic risk factors of chronic obstructive pulmonary disease Swiss Med Wkly 132 2002 27-37
5. Poller W. Faber J.P. Scholz S. et al. Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease Lancet 339 1992 1538
6. Joos L. He J.Q. Shepherdson M.B. et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function Hum Mol Genet 11 2002 569-576
7. Hirano K. Sakamoto T. Uchida Y. et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease Eur Respir J 18 2001 748-752
8. Kwok P.Y. SNP genotyping with fluorescence polarization detection Hum Mutat 19 2002 315-323
9. Kim C.H. Oh Y. Lee T.H. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells Gene 199 1997 293-301
10. Ross J. mRNA stability in mammalian cells Microbiol Rev 59 1995 423-450
11. Jurevic R.J. Chrisman P. Mancl L. Livingston R. Dale B.A. Single-nucleotide polymorphisms and haplotype analysis in beta-defensin genes in different ethnic populations Genet Test 6 2002 261-269
12. Huang S.L. Su C.H. Chang S.C. Tumor necrosis factor-α gene polymorphism in chronic bronchitis Am J Respir Crit Care Med 156 1998 1436-1439
13. Higham M.A. Pride N.B. Alikhan A. Morrell N.W. Tumour necrosis factor-α gene promoter polymorphisms in chronic obstructive pulmonary disease Eur Respir J 15 2002 281-284
14. Ishii T. Matsuse T. Teramoto S. et al. Neither IL-1β, IL-1 receptor antagonist, nor TNFα polymorphisms are associated with susceptibility to COPD Respir Med 94 2000 847-851